Clinical correlates of circulating cell-free DNA tumor fraction

Oncology applications of cell-free DNA analysis are often limited by the amount of circulating tumor DNA and the fraction of cell-free DNA derived from tumor cells in a blood sample. This circulating tumor fraction varies widely between individuals and cancer types. Clinical factors that influence tumor fraction have not been completely elucidated.Circulating tumor fraction was determined for breast, lung, and colorectal cancer participant...